KEAP1 and neoplasm: Moreover, NRF2 promotes GSH synthesis also from a metabolic point of view as demonstrated in tumours bearing mutated Kelch-like ECH-associated protein 1 (KEAP1), a negative regulator of NRF2 stability, in which glutamine-derived glutamate is used for GSH production at the expense of the Krebs cycle [28].